Sleep and cancer recurrence and survival in patients with resected Stage III colon cancer: findings from CALGB/SWOG 80702 (Alliance)
      QxMD      Google Scholar   
Citation:
Br J Cancer vol 129 (2) 283-290
Year:
2023
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
Alliance-data-source,-internal-user
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
12
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
GI
Sec. Committees:
   
Pharmas:
Pfizer  
Grants:
U10CA180821, U10CA180882, U10CA180794, UG1CA233253, UG1CA233290, UG1CA233320, UG1CA233337, UG1CA233339, UG1CA189954, U10CA180863 CCTG, UG1CA233196, U10CA180820 ECOG-ACRIN, U10CA180868 NRG, U10CA180888 and UG1CA233163 SWOG, R00CA218603, P30 CA008748, P30 CA015083 , UG1 CA233180  
Corr. Author:
 
Authors:
                           
Networks:
HEARTLAND, LAPS-MA036, LAPS-MO011, LAPS-NY016, OH027, SCOR   
Study
Alliance-A151939
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-80702
Phases:
N/A, 3
Keywords:
Colon cancer, Outcomes research, Chemotherapy